Hematol Oncol Clin North Am. 2011 Oct;25(5):1025-48, vi.

Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.

Source

Section of Hematology/Oncology, Department of Medicine, University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, USA.

Abstract

In the pre-tyrosine kinase (TKI) era, allogeneic stem cell transplant (allo-SCT) was the front-line treatment of choice for young patients with chronic myelogenous leukemia (CML). Today, imatinib is well established as front-line therapy for CML, with excellent long-term outcomes. This has changed the role of allo-SCT and the number of patients undergoing allo-SCT has declined dramatically. Allo-SCT is currently recommended for patients in accelerated/blast phase disease, those who have failed a second-generation TKI and those with TKI-resistant mutations such as T315I. The role of allo-SCT in the management of CML will require continual reappraisal as medical therapies continue to evolve.

PMID:: 22054733; [PubMed - indexed for MEDLINE]
PMCID:: PMC3246008; [Available on 2012/10/1]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Chronic Myeloid Leukemia - MedlinePlus Health Information

Molecular Biology Databases

IMATINIB MESYLATE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure. [Blood. 2006]
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.
Jabbour E, Cortes J, Kantarjian HM, Giralt S, Jones D, Jones R, Giles F, Andersson BS, Champlin R, de Lima M. Blood. 2006 Aug 15; 108(4):1421-3. Epub 2006 Apr 6.
Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315I. [Cancer. 2010]
Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315I.
Velev N, Cortes J, Champlin R, Jones D, Rondon G, Giralt S, Borthakur G, Kantarjian HM, De Lima M. Cancer. 2010 Aug 1; 116(15):3631-7.
Allogeneic stem cell transplantation for chronic myeloid leukemia-status in 2007. [Bone Marrow Transplant. 2008]
Allogeneic stem cell transplantation for chronic myeloid leukemia-status in 2007.
Goldman J. Bone Marrow Transplant. 2008 Aug; 42 Suppl 1:S11-S13.
Review Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation. [Hematology Am Soc Hematol Educ...]
Review Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation.
Suttorp M, Millot F. Hematology Am Soc Hematol Educ Program. 2010; 2010:368-76.
Review Targeted chronic myeloid leukemia therapy: Seeking a cure. [Am J Health Syst Pharm. 2007]
Review Targeted chronic myeloid leukemia therapy: Seeking a cure.
Fausel C. Am J Health Syst Pharm. 2007 Dec 15; 64(24 Suppl 15):S9-15.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.
Hematol Oncol Clin North Am. 2011 Oct ;25(5):1025-48, vi.

PubMed
In vitro and in vivo behaviour of sympatric Leishmania (V.) braziliensis, L. (V....
In vitro and in vivo behaviour of sympatric Leishmania (V.) braziliensis, L. (V.) peruviana and their hybrids.
Parasitology. 2012 Feb ;139(2):191-9. Epub 2011 Nov 7 .

PubMed
Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to th...
Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen.
Virol J. 2011 Nov 4 ;8:507.

PubMed
Long-term home oxygen therapy.
Long-term home oxygen therapy.
Clin Chest Med. 1990 Sep ;11(3):505-21.

PubMed
Re: radiotherapy and short-term androgen deprivation for localized prostate canc...
Re: radiotherapy and short-term androgen deprivation for localized prostate cancer.
Eur Urol. 2011 Dec ;60(6):1306.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: